HEALTH● LOW4d ago · Oct 9, 2026, 3:21 PM
Teva gains approval of monthly olanzapine injection for schizophrenia
Seeking Alpha Tech · global
Teva has received approval for a monthly olanzapine injection used to treat schizophrenia. This development offers a new treatment option for individuals suffering from the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH5m agoClimate change is putting Europe’s brain health at riskEuroNews [en]HEALTH14m agoOlympic Qualifier: Eguavoen speaks on Ajibade’s injury, hails Okpe after big winPremium TimesHEALTH29m agoMother's journey with sick child highlights Somalia's malnutrition emergencyAfricanews [en]HEALTH29m agoProgress against HIV stalls in South Africa, research showsThe Telegraph